1887

Abstract

Structure–function analysis of the hepatitis C virus (HCV) envelope glycoproteins, E1 and E2, has been difficult due to the unavailability of HCV virions. Truncated soluble forms of E2 have been used as models to study virus interaction with the putative HCV receptor CD81, but they may not fully mimic E2 structures on the virion. Here, we compared the CD81-binding characteristics of truncated E2 (E2) and full-length (FL) E1E2 complex expressed in mammalian cells, and of HCV virus-like particles (VLPs) generated in insect cells. All three glycoprotein forms interacted with human CD81 in an binding assay, allowing us to test a panel of well-characterized anti-E2 monoclonal antibodies (MAbs) for their ability to inhibit the glycoprotein–CD81 interaction. MAbs specific for E2 amino acid (aa) regions 396–407, 412–423 and 528–535 blocked binding to CD81 of all antigens tested. However, MAbs specific for regions 432–443, 436–443 and 436–447 inhibited the interaction of VLPs, but not of E2 or the FL E1E2 complex with CD81, indicating the existence of structural differences amongst the E2 forms. These findings underscore the need to carefully select an appropriate ligand for structure–function analysis.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-8-1877
2001-08-01
2019-08-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/8/0821877a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-8-1877&mimeType=html&fmt=ahah

References

  1. Agnello, V., Abel, G., Elfahal, M., Knight, G. B. & Zhang, Q. X. ( 1999; ). Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proceedings of the National Academy of Sciences, USA 96, 12766-12771.[CrossRef]
    [Google Scholar]
  2. Baumert, T. F., Ito, S., Wong, D. T. & Liang, T. J. ( 1998; ). Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. Journal of Virology 72, 3827-3836.
    [Google Scholar]
  3. Baumert, T. F., Vergalla, J., Satoi, J., Thomson, M., Lechmann, M., Herion, D., Greenberg, H. B., Ito, S. & Liang, T. J. ( 1999; ). Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology 117, 1397-1407.[CrossRef]
    [Google Scholar]
  4. Cardoso, M. D., Siemoneit, K., Strum, D., Krone, C., Moradpour, D. & Kubanek, B. ( 1998; ). Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins. Journal of Medical Virology 55, 28-34.[CrossRef]
    [Google Scholar]
  5. Chan-Fook, C., Jiang, W. R., Clarke, B. E., Zitzmann, N., Maidens, C., McKeating, J. A. & Jones, I. M. ( 2000; ). Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity. Virology 273, 60-66.[CrossRef]
    [Google Scholar]
  6. Choukhi, A., Ung, S., Wychowski, C. & Dubuisson, J. ( 1998; ). Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. Journal of Virology 72, 3851-3858.
    [Google Scholar]
  7. Clarke, B. ( 1997; ). Molecular virology of hepatitis C virus. Journal of General Virology 78, 2397-2410.
    [Google Scholar]
  8. Cocquerel, L., Meunier, J. C., Pillez, A., Wychowski, C. & Dubuisson, J. ( 1998; ). A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. Journal of Virology 72, 2183-2191.
    [Google Scholar]
  9. Cocquerel, L., Duvet, S., Meunier, J. C., Pillez, A., Cacan, R., Wychowski, C. & Dubuisson, J. ( 1999; ). The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum. Journal of Virology 73, 2641-2649.
    [Google Scholar]
  10. Deleersnyder, V., Pillez, A., Wychowski, C., Blight, K., Xu, J., Hahn, Y. S., Rice, C. M. & Dubuisson, J. ( 1997; ). Formation of native hepatitis C virus glycoprotein complexes. Journal of Virology 71, 697-704.
    [Google Scholar]
  11. Dubuisson, J. ( 2000; ). Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Current Topics in Microbiology and Immunology 242, 135-148.
    [Google Scholar]
  12. Dubuisson, J., Hsu, H. H., Cheung, R. C., Greenberg, H. B., Russell, D. G. & Rice, C. M. ( 1994; ). Formation and intracellular-localization of hepatitis-C virus envelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses. Journal of Virology 68, 6147-6160.
    [Google Scholar]
  13. Duvet, S., Cocquerel, L., Pillez, A., Cacan, R., Verbert, A., Moradpour, D., Wychowski, C. & Dubuisson, J. ( 1998; ). Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. Journal of Biological Chemistry 273, 32088-32095.[CrossRef]
    [Google Scholar]
  14. Farci, P., Shimoda, A., Wong, D., Cabezon, T., DeGioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J. & Purcell, R. H. ( 1996; ). Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proceedings of the National Academy of Sciences, USA 93, 15394-15399.[CrossRef]
    [Google Scholar]
  15. Flint, M. & McKeating, J. A. ( 1999; ). The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum. Journal of General Virology 80, 1943-1947.
    [Google Scholar]
  16. Flint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S. & McKeating, J. A. ( 1999; ). Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. Journal of Virology 73, 6235-6244.
    [Google Scholar]
  17. Flint, M., Dubuisson, J., Maidens, C., Harrop, R., Guile, G. R., Borrow, P. & McKeating, J. A. ( 2000; ). Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. Journal of Virology 74, 702-709.[CrossRef]
    [Google Scholar]
  18. Forns, X., Allander, T., Rohwer-Nutter, P. & Bukh, J. ( 2000; ). Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface. Virology 274, 75-85.[CrossRef]
    [Google Scholar]
  19. Habersetzer, F., Fournillier, A., Dubuisson, J., Rosa, D., Abrignani, S., Wychowski, C., Nakano, I., Trepo, C., Desgranges, C. & Inchauspe, G. ( 1998; ). Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology 249, 32-41.[CrossRef]
    [Google Scholar]
  20. Hadlock, K. G., Lanford, R. E., Perkins, S., Rowe, J., Yang, Q., Levy, S., Pileri, P., Abrignani, S. & Foung, S. K. ( 2000; ). Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. Journal of Virology 74, 10407-10416.[CrossRef]
    [Google Scholar]
  21. Kato, N., Ootsuyama, Y., Tanaka, T., Nakagawa, M., Nakazawa, T., Muraiso, K., Ohkoshi, S., Hijikata, M. & Shimotohno, K. ( 1992; ). Marked sequence diversity in the putative envelope proteins of hepatitis-C viruses. Virus Research 22, 107-123.[CrossRef]
    [Google Scholar]
  22. Levy, S., Todd, S. C. & Maecker, H. T. ( 1998; ). CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annual Review of Immunology 16, 89-109.[CrossRef]
    [Google Scholar]
  23. Meola, A., Sbardellati, A., Bruni Ercole, B., Cerretani, M., Pezzanera, M., Ceccacci, A., Vitelli, A., Levy, S., Nicosia, A., Traboni, C., McKeating, J. & Scarselli, E. ( 2000; ). Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. Journal of Virology 74, 5933-5938.[CrossRef]
    [Google Scholar]
  24. Michalak, J. P., Wychowski, C., Choukhi, A., Meunier, J. C., Ung, S., Rice, C. M. & Dubuisson, J. ( 1997; ). Characterization of truncated forms of hepatitis C virus glycoproteins. Journal of General Virology 78, 2299-2306.
    [Google Scholar]
  25. Mizushima, H., Hijikata, M., Asabe, S., Hirota, M., Kimura, K. & Shimotohno, K. ( 1994; ). Two hepatitis C virus glycoprotein E2 products with different C termini. Journal of Virology 68, 6215-6222.
    [Google Scholar]
  26. Ogata, N., Alter, H. J., Miller, R. H. & Purcell, R. H. ( 1991; ). Nucleotide-sequence and mutation-rate of the H-strain of hepatitis-C virus. Proceedings of the National Academy of Sciences, USA 88, 3392-3396.[CrossRef]
    [Google Scholar]
  27. Patel, J., Patel, A. H. & McLauchlan, J. ( 1999; ). Covalent interactions are not required to permit or stabilize the non-covalent association of hepatitis C virus glycoproteins E1 and E2. Journal of General Virology 80, 1681-1690.
    [Google Scholar]
  28. Patel, A. H., Wood, J., Penin, F., Dubuisson, J. & McKeating, J. A. ( 2000; ). Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. Journal of General Virology 81, 2873-2883.
    [Google Scholar]
  29. Petracca, R., Falugi, F., Galli, G., Norais, N., Rosa, D., Campagnoli, S., Burgio, V., Di Stasio, E., Giardina, B., Houghton, M., Abrignani, S. & Grandi, G. ( 2000; ). Structure-function analysis of hepatitis C virus envelope-CD81 binding. Journal of Virology 74, 4824-4830.[CrossRef]
    [Google Scholar]
  30. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G. & Abrignani, S. ( 1998; ). Binding of hepatitis C virus to CD81. Science 282, 938-941.[CrossRef]
    [Google Scholar]
  31. Ralston, R., Thudium, K., Berger, K., Kuo, C., Gervase, B., Hall, J., Selby, M., Kuo, G., Houghton, M. & Choo, Q. L. ( 1993; ). Characterization of hepatitis-C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. Journal of Virology 67, 6753-6761.
    [Google Scholar]
  32. Rice, C. M. ( 1996; ). Flaviviridae: the viruses and their replication. In Fields Virology , pp. 931-959. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia:Lippincott–Raven.
  33. Rosa, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dong, C., Weiner, A. J., Lau, J. Y. N., Choo, Q. L., Chien, D., Pileri, P., Houghton, M. & Abrignani, S. ( 1996; ). A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proceedings of the National Academy of Sciences, USA 93, 1759-1763.[CrossRef]
    [Google Scholar]
  34. Ryan, M. D., Monaghan, S. & Flint, M. ( 1998; ). Virus-encoded proteinases of the Flaviviridae. Journal of General Virology 79, 947-959.
    [Google Scholar]
  35. Shimizu, Y. K., Igarashi, H., Kiyohara, T., Cabezon, T., Farci, P., Purcell, R. H. & Yoshikura, H. ( 1996; ). A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223, 409-412.[CrossRef]
    [Google Scholar]
  36. Weiner, A. J., Brauer, M. J., Rosenblatt, J., Richman, K. H., Tung, J., Crawford, K., Bonino, F., Saracco, G., Choo, Q. L., Houghton, M. & Han, J. H. ( 1991; ). Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and Ns1 proteins and the pestivirus envelope glycoproteins. Virology 180, 842-848.[CrossRef]
    [Google Scholar]
  37. Wunschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N. & Stapleton, J. T. ( 2000; ). Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. Journal of Virology 74, 10055-10062.[CrossRef]
    [Google Scholar]
  38. Yagnik, A. T., Lahm, A., Meola, A., Roccasecca, R. M., Ercole, B. B., Nicosia, A. & Tramontano, A. ( 2000; ). A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40, 355-366.[CrossRef]
    [Google Scholar]
  39. Yanagi, M., Purcell, R. H., Emerson, S. U. & Bukh, J. ( 1997; ). Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proceedings of the National Academy of Sciences, USA 94, 8738-8743.[CrossRef]
    [Google Scholar]
  40. Zibert, A., Schreier, E. & Roggendorf, M. ( 1995; ). Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208, 653-663.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-8-1877
Loading
/content/journal/jgv/10.1099/0022-1317-82-8-1877
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error